An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.
about
Chemotherapy versus best supportive care for extensive small cell lung cancerChemotherapy versus best supportive care for extensive small cell lung cancerDiagnosis and management of hyponatremia in cancer patientsRandomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma.Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.Methodological challenges in the evaluation of prognostic factors in breast cancer.Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapyPrognostic factors for limited-stage small cell lung cancer: a study of 284 patients.Evaluating prognostic factors: implications for measurement of health care outcome.De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke.Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.Chemotherapy for small cell lung cancer: a comprehensive reviewRatio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung CancerA randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung CancAnalysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survivalA Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer.Prognosis in lung cancer: physicians' opinions compared with outcome and a predictive modelSubcarinal node is the significant node that affects survival in resected small cell lung cancer.Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994A microRNA-related single nucleotide polymorphism of the XPO5 gene is associated with survival of small cell lung cancer patients.Progress in the management of limited-stage small cell lung cancer.Neuropeptide growth factors and cancer.Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients.Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.Syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) as an initial presenting sign of non small cell lung cancer-case report and literature review.Statistical aspects of prognostic factor studies in oncology.Ferulic Acid modulates altered lipid profiles and prooxidant/antioxidant status in circulation during nicotine-induced toxicity: a dose-dependent study.Anemia as an independent prognostic factor for survival in patients with cancer.Dose-response effect of ferulic acid against nicotine-induced tissue damage and altered lipid levels in experimental rats: a pathohistological evaluation.The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma.Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
P2860
Q24240652-E79B209E-F22B-4379-B94F-D4579A371F84Q24247718-65676DB3-551F-4387-860C-E92705ABD8B3Q27027817-29C178DC-18B5-4747-BB37-604BCE4D82C9Q33338538-01519E68-917B-4946-8147-67A95F428671Q33391448-B4E2CEEA-612B-4E9C-AC80-0301D18D320AQ33436297-CCFDF900-D991-474F-8E09-4F8C31C74192Q33538459-580272BC-00DE-4278-A85B-39950D319586Q33618900-34F47835-6355-4711-83A9-0732575DAA8EQ33625372-BB572488-9102-4296-AF95-DA3362BEDFE2Q33701109-A4797A93-791F-429A-9BB2-685E67A19B23Q33817919-3E1CCFFC-9097-4DC7-A780-9DED28D7C987Q34982142-20FB45E2-8675-410A-B09A-F482B38ECAFBQ34991328-102B2E98-4AD8-4A71-B46C-668A299F7347Q35569379-8CB63170-6AD8-471C-8FD8-BE5A7A6997D4Q35754078-6CA919D0-92C4-44F8-BCBB-2FAFC0650C8CQ35977461-E79B38D5-B20E-4947-AB6D-604008408F7FQ35984841-25D91D7A-5C1E-44DC-88EF-7ACAF050880EQ35993823-0983D934-7B30-4F7F-B427-8E30F2F6D8B7Q35994459-EDD77C17-E74F-4023-87B9-EBC3F04D26E6Q36135418-1B45C36B-0561-4205-AE87-554475BBCB63Q36135716-17A54624-441C-48A9-A3AB-CAF13BD946B1Q36224408-9F187F5E-83E2-4BF9-BC71-AE81AFFD980AQ36500218-42F7995B-8A26-46A6-A72D-A25C0A26F368Q36545860-BE38AC06-47A8-4985-88C4-5384DD8E42A9Q36643410-F305BB61-2585-425B-AE74-50764930F99BQ37565272-9F702F6D-882F-4A8F-AD34-C24CCFBEEFC1Q37626969-C154E66E-027C-499F-AC07-F318E435E46DQ37664018-E569D018-5830-4A32-95A7-DBA377CDB15FQ37702774-BD37F671-CE53-4402-9343-E79A9EF71AB0Q37982977-4C4B5AD7-1FD4-4830-9A85-3DFA960CEF2CQ38698128-E3504915-5938-4E84-B436-4A1702928164Q39070636-0BF1C98A-18E9-4788-ADE5-CB951EAF23FDQ39735678-AF42528D-2BE7-422D-BD2E-F77023FA6983Q40073736-FC2B0C83-D0F5-4544-BBC2-2C170DCC7EA0Q42388377-2EE33117-E39D-4E7B-9017-B76B8ADBB672Q43215653-D0AF2E0F-9F71-44AD-8C63-0A421D87F124Q43680780-ECDBE252-6277-4FD1-BCE6-913D33D4E683Q46323837-4568AE5D-0DEE-4D3D-A57C-CC3AB21C980EQ50050970-04EFA385-E55C-4675-959C-FDF97C099F82Q50902074-1732DC9F-34B6-4398-B22F-7D05C2A36667
P2860
An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
An overview of prognostic fact ...... Committee on Cancer Research.
@ast
An overview of prognostic fact ...... Committee on Cancer Research.
@en
type
label
An overview of prognostic fact ...... Committee on Cancer Research.
@ast
An overview of prognostic fact ...... Committee on Cancer Research.
@en
prefLabel
An overview of prognostic fact ...... Committee on Cancer Research.
@ast
An overview of prognostic fact ...... Committee on Cancer Research.
@en
P2860
P356
P1476
An overview of prognostic fact ...... Committee on Cancer Research.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1990.133
P407
P577
1990-04-01T00:00:00Z
P6179
1053201549